Searched for
TORRENT PHARMA CIPLA DEAL NEWS
Global Market Today: Asian stocks fall on Korean chip selloff, oil dipsAsian markets tumbled as chipmaker stocks experienced a sharp decline, sparking fears the AI rally might have overheated. Concerns also sur...- Shutterstock shares crash 29% after Getty Images calls off $3.7 billion mergerShutterstock shares plunged nearly 30% after Getty Images scrapped its $3.7 billion merger following UK regulator objections. The Competiti...
- CCI clears RCB's $1.78-billion buyout by Aditya Birla Group, ToI consortiumThe Competition Commission of India has greenlit a massive $1.78 billion deal, allowing a consortium led by Aditya Birla Group and The Time...
- Paramount moves to ease EU antitrust concerns over Warner Bros Discovery dealParamount Skydance Corp has offered solutions to EU competition watchdogs regarding its massive Warner Bros Discovery acquisition. The comp...
- Schneider Electric signs deal to buy AI software player Cognite for $3.1 billionThe French multinational said in a press release it would pay $3.1 billion for the whole of Cognite in an all cash deal.
- UK may intervene in $110 billion Paramount-Warner Bros Discovery dealBritain is considering intervening in Paramount's proposed $110 billion takeover of Warner Bros Discovery, potentially delaying the deal de...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Drone startup Elroy Air to list on Nasdaq via $1 billion SPAC dealCargo drone startup Elroy Air is set to go public in the US through a $1 billion merger with blank-check firm Columbus Circle Capital Corp ...
- Rubio warns Hormuz tolls would 'spread like contagion' to other waterwaysUS Secretary of State Marco Rubio on Thursday warned that Iranian tolls on ships passing the Strait of Hormuz would spread to other waterwa...
- Stocks in news: Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, Tata MotorsIndian markets experienced profit booking, falling over a percent amidst a weak global trend. Key stocks like Vedanta, Honasa Consumer, IRC...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
Load More
